Loading data
DARENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.03 m USD | 9.78 k USD | 2.81 m USD | 10 m USD | 0 USD |
| Cost of revenue | 295.8 k USD | 0 USD | — | — | — |
| Research and development expense | 5.52 m USD | 14.31 m USD | 21.54 m USD | 30.04 m USD | 30.62 m USD |
| Selling, general and administrative expense | 8.76 m USD | 9.16 m USD | — | — | — |
| Operating profit | -13.55 m USD | -23.45 m USD | -30.94 m USD | -31.39 m USD | -39.07 m USD |
| Profit before tax | -13.54 m USD | -4.05 m USD | -30.16 m USD | -30.95 m USD | -38.7 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -13.4 m USD | -4.05 m USD | -30.16 m USD | -30.95 m USD | -38.7 m USD |
| Net income attributable to common shareholders | -13.4 m USD | -4.05 m USD | -30.16 m USD | -30.95 m USD | -38.7 m USD |
| Basic earnings per share | -1.2 USD/share | -0.48 USD/share | -4.15 USD/share | -0.37 USD/share | -0.63 USD/share |
| Diluted earnings per share | -1.2 USD/share | -0.48 USD/share | -4.15 USD/share | -0.37 USD/share | -0.63 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.